Pokhrel, LaxmanMaezawa, IzumiNguyen, Thi D.T.Chang, Kyeong-OkJin, Lee-WayHua, Duy H.2012-12-112012-12-112012-10-01http://hdl.handle.net/2097/15172Alzheimer’s disease (AD) is the most common cause of dementia in the elderly. A major effort in AD therapeutic development has targeted Aβ and downstream events. We have taken a rational design approach and synthesized a small library of tricyclic pyrone compounds based on CP2. Their protective action in MC65 cells and the inhibition of acyl‐CoA:cholesterol acyltransferase along with the upregulation of cholesterol transporter gene were investigated. Five most active compounds exhibited potencies in the nanomolar to low micromolar ranges. The multiple effects of the compounds on Aβ and cellular cholesterol pathways could be potential mechanisms underlying the protective effects in vivo.en-USThis Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s).Alzheimer’s diseaseAβTricyclic pyrone moleculesCholesterol transporter geneAcyl‐CoA:cholesterol acyltransferaseArticle (author version)